Fact Sheets

HR 2739 – Cancer Drug Coverage Parity Act of 2015

Please cosponsor H.R. 2739, the Cancer Drug Coverage Parity Act, to ensure every cancer patient has access to the anticancer treatments recommended by their physicians.

S.1566 – Cancer Treatment Parity Act of 2015

Please cosponsor S. 1566, The Cancer Drug Coverage Parity Act, to ensure every cancer patient has access to the anticancer treatments recommended by their physicians

Missions & Goals

Equal reimbursement parity for anticancer regimens regardless of delivery method including, but not limited to oral and intravenous drugs, injections, surgery, radiation, transplantation, etc.

Oral Chemo Abandonment Study

To calculate the abandonment rate of oral oncolytic medications and identify factors that may affect likelihood of abandonment.

Indiana Department of Insurance Oral Chemo Implementation Study

Questions regarding Oral Chemo Implementation Study

Texas Department of Insurance Report on Oral Chemo Bill

Patient Cost Disparity between Orally and Intravenously Administered Chemotherapies

Vermont Oral Anticancer Medication Report

Coverage of Oral Anticancer Medication

Milliman Study on Oral Parity Implementation

Parity for Oral and Intravenous/Injected Cancer Drugs